Month: March 2025

Announcement no. 2-2025 3 March 2025 North Media A/S expands its Group Executive Board from four to five members as a step in the process to strengthen the Group. Ask Illum Jessen has as of 1 March 2025 taken up the position as Group Chief Infrastructure and Commercial Optimisation Officer (CICO).  North Media runs and develops companies that are capable of delivering and handling high volumes efficiently, quickly and at low unit costs. That requires, among other things, well-developed infrastructures, building on a high degree of automation and digitalisation. As Group Chief Infrastructure and Commercial Optimisation Officer, Ask Jessen’s responsibilities will include the building of strong commercial infrastructures across the Group.  Ask will – in cooperation with the other members of the Group Executive Board and the management teams...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSSt Peter Port, Guernsey 4 March 2025 NB Private Equity Partners Limited (“NBPE” or the “Company”) Total Voting Rights Total Voting Rights In accordance with DTR 5.6.1R, NB Private Equity Partners Limited (“NBPE” or the “Company”) notifies the market of the following:Class of Share Number in issue as at 28 February 2025 Voting Entitlement pursuant to the Articles of Incorporation Number held in Treasury as at 28 February 2025 Voting Rights as at 28 February 2025Class A Ordinary 49,146,884 May attend and vote at general meetings 3,150,408 45,996,476Class A Shareholders have the right to receive notice of general meetings of the Company and...

Cnova NV appoints interim CFO 4 March 2025, 8:30 CET Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) announces the appointment of Mrs. Marie Even as interim CFO. Marie Even has been Deputy CEO of Cdiscount since August 2020, overseeing the General Secretary and Cnova Pay, a financial entity managing marketplace financial flows and installment payments. In addition to this role, she is now appointed interim Chief Financial Officer of Cnova. Since April 2024, she has also been in charge of Transformation. Marie joined Cnova in 2009 as Head of Legal Affairs. She was later appointed General Secretary in 2017, overseeing Legal, HR, CSR, Corporate Communication, DPO, and Public Affairs. Prior to that, she served as Head of Group Legal for 2H Technologies and practiced as a lawyer at Deloitte law firm for six years....

Oslo, Norway – IDEX Biometrics has received a production order from the manufacturing partner Beautiful Card Corporation (BCC). The order has a value of approx. USD 50,000 and is the first of a larger biometric payment card program issued across both Mastercard and Visa for the Japanese market. “BCC is a clear front-runner, with a commitment to bring biometric smart cards to customers and partners world-wide, for payment and access cards. As IDEX and BCC already have material ready for production, we have been able to respond to our partners’ imminent implementation program”, comments Catharina Eklof, Chief Executive Officer at IDEX Biometrics. For further information contact: Marianne Bøe, Head of Investor Relations, + 47 91800186Kristian Flaten, CFO, +47 95092322 E-mail:ir@idexbiometrics.com About IDEX BiometricsIDEX...

MELBOURNE, Australia, March 03, 2025 (GLOBE NEWSWIRE) — World-leading photomedicine company CLINUVEL will make its début at the American Academy of Dermatology (AAD) Annual Meeting from March 7–11, with an immersive exhibition that illuminates the past, present and future of photomedicine. The 4,800-square-foot Pavilion of Photomedicine has been custom built for CLINUVEL for the AAD Meeting to provide an immersive experience on the history, evolution, and future of photomedicine, including CLINUVEL’s development program with the novel drug SCENESSE® (afamelanotide) to treat vitiligo and work with other melanocortins. Visitors will travel through five curated courts to experience CLINUVEL’s world of innovation, from the origins of their pioneering melanocortin technology to the ongoing clinical trials that are defining a new approach...

MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, March 10, 2025, in Miami, FL. Management will also host investor meetings during the conference. The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com. About NeuroPace, Inc. Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or...

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) — Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQX, 3RI-FSE) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the “Offering”) for aggregate gross proceeds of $5,000,000, from the issuance of 100,000,000 common shares in the capital of the Company (the “Shares”) at a price of $0.05 per Share. The net proceeds of the Offering will be used to satisfy continuing costs associated with the Company’s properties and for general working capital purposes. In connection with closing of the Offering, the Company issued an aggregate of 1,746,500 Shares to certain eligible arm’s length finders. All securities issued in connection with closing of the Offering are subject to a statutory hold period...

CHANDLER, Ariz., March 03, 2025 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Raymond James 46ᵗʰ Annual Investors Conference on Wednesday, March 5, 2025 at 9:50 a.m. (Eastern Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer, and Mr. Sajid Daudi, Head of Investor Relations. A live webcast of the presentation will be made available by Raymond James, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies...